Literature DB >> 9158777

Identification of DNA gyrase A mutations in ciprofloxacin-resistant isolates of Salmonella typhimurium from men and cattle in Germany.

P Heisig1, B Kratz, E Halle, Y Gräser, M Altwegg, W Rabsch, J P Faber.   

Abstract

Six multiply resistant isolates of Salmonella typhimurium var. copenhagen with high-level resistance to fluoroquinolones (e.g., MIC of ciprofloxacin: 32 micrograms/ml) were isolated from human patients (n = 3) and from cattle (n = 3). The isolates were examined by complementation tests using a set of broad-host-range plasmids, which carry either the gyrA+ or the gyrB+ genes or a combination of both from Escherichia coli K-12. The results indicated a combination of gyrA and gyrB mutations in all isolates. Subsequent direct sequencing of PCR-generated internal DNA fragments of gyrA revealed an identical double mutation in all six isolates (Ser-83-->Ala and Asp-87-->Asn). In addition, the results of phenotypic (i.e., phagetype, biotype, serotype) and genotypic characterization [i.e., ribotyping and polymerase chain reaction fingerprinting (PCR-fingerprinting)] were identical for all six isolates and were distinguishable from a quinolone-susceptible strain of the same serovar and an unrelated isolate of S. typhimurium. These data indicate the clonal identity of the fluoroquinolone-resistant strains of S. typhimurium isolated from men and cattle in Germany.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9158777     DOI: 10.1089/mdr.1995.1.211

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  12 in total

1.  gyrA Mutations associated with nalidixic acid-resistant salmonellae from wild birds.

Authors:  M Paloma Reche; José E García de los Ríos; Pedro A Jiménez; Ana M Rojas; Rafael Rotger
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

2.  Multiple resistance mechanisms in fluoroquinolone-resistant Salmonella isolates from Germany.

Authors:  Beatriz Guerra; Burkhard Malorny; Andreas Schroeter; Reiner Helmuth
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

3.  Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones.

Authors:  Anne Olliver; Michel Vallé; Elisabeth Chaslus-Dancla; Axel Cloeckaert
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Topoisomerase sequences of coagulase-negative staphylococcal isolates resistant to ciprofloxacin or trovafloxacin.

Authors:  D T Dubin; J E Fitzgibbon; M D Nahvi; J F John
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

Review 5.  Mechanisms of fluoroquinolone resistance: an update 1994-1998.

Authors:  L J Piddock
Journal:  Drugs       Date:  1999       Impact factor: 9.546

6.  Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field.

Authors:  E Giraud; A Brisabois; J L Martel; E Chaslus-Dancla
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

7.  Comparison of gyrA mutations, cyclohexane resistance, and the presence of class I integrons in Salmonella enterica from farm animals in England and Wales.

Authors:  Ernesto Liebana; Carol Clouting; Claire A Cassar; Luke P Randall; Rachel A Walker; E John Threlfall; Felicity A Clifton-Hadley; Anne M Ridley; Robert H Davies
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

8.  Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.

Authors:  P Heisig
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  Multidrug resistance in Salmonella enterica serotype Typhimurium from humans in France (1993 to 2003).

Authors:  François-Xavier Weill; Françoise Guesnier; Véronique Guibert; Mohammed Timinouni; Marie Demartin; Lucette Polomack; Patrick A D Grimont
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  A mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase II.

Authors:  Thomas Gruger; John L Nitiss; Anthony Maxwell; E Lynn Zechiedrich; Peter Heisig; Siegfried Seeber; Yves Pommier; Dirk Strumberg
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.